BEUDAMED
    FDA Adverse Event Injury Summary report: N

    RUNTHROUGH

    MDR report key: 23069842 · Received September 16, 2025

    Report

    Report Number
    9681834-2025-00171
    Event Type
    Injury
    Date Received
    September 16, 2025
    Date of Event
    August 18, 2025
    Report Date
    September 16, 2025
    Manufacturer
    TERUMO CORPORATION, ASHITAKA
    Product Code
    DQX
    UDI-DI
    04987350744340
    PMA / PMN Number
    K063695
    Adverse Event
    Yes
    Product Problem
    Yes
    Report Source
    Manufacturer report
    Reporter Location
    WV, US
    Reporter Occupation
    OTHER HEALTH CARE PROFESSIONAL
    Health Professional
    Yes

    Narratives

    Additional Manufacturer Narrative · 0

    A1: PATIENT IDENTIFIER: REQUESTED, NOT PROVIDED. A2: AGE OR DATE OF BIRTH: REQUESTED, NOT PROVIDED. A3A: SEX: REQUESTED, NOT PROVIDED . A4: WEIGHT: REQUESTED, NOT PROVIDED . A5: ETHNICITY: REQUESTED, NOT PROVIDED . A6: RACE: REQUESTED, NOT PROVIDED . D6A: IMPLANTED DATE: DEVICE WAS NOT IMPLANTED . D6B: EXPLANTED DATE: DEVICE WAS NOT EXPLANTED . THE ACTUAL DEVICE HAS NOT BEEN RETURNED FOR EVALUATION. THE INVESTIGATION IS CURRENTLY ONGOING. A FOLLOW-UP REPORT WILL BE SUBMITTED ONCE THE INVESTIGATION IS COMPLETE. NO ANOMALIES WERE IDENTIFIED IN THE MANUFACTURING OR SHIPPING INSPECTION RECORDS ASSOCIATED WITH THE REPORTED PRODUCT CODE AND LOT NUMBER. NO SIMILAR COMPLAINTS WERE FOUND IN THE HISTORICAL COMPLAINT FILES. PLEASE REFER TO SECTION H10 FOR THE IMPORTER'S REPORT RELATED TO THIS EVENT. TERUMO MEDICAL CORPORATION (TMC) (IMPORTER) REGISTRATION NO. (B)(4) IS SUBMITTING THIS REPORT ON BEHALF OF ASHITAKA FACTORY OF TERUMO CORPORATION (MANUFACTURER) REGISTRATION NO. (B)(4).

    Additional Manufacturer Narrative · 0

    THIS REPORT IS BEING SUBMITTED AS FOLLOW UP NO. 1 TO PROVIDE THE COMPLETED INVESTIGATION RESULTS. THE ACTUAL DEVICE WAS NOT RETURNED; THEREFORE, AN EVALUATION OF THE ACTUAL DEVICE WAS UNABLE TO BE CONDUCTED. NO ANOMALY WAS FOUND IN THE MANUFACTURING RECORD AND THE SHIPPING INSPECTION RECORD. NO OTHER SIMILAR REPORT WAS FOUND IN THE PAST COMPLAINT FILE. BASED ON THE INVESTIGATION RESULT, NO ANOMALY WAS FOUND IN THE MANUFACTURING RECORD AND THE SHIPPING INSPECTION RECORD. HOWEVER, SINCE THE ACTUAL DEVICE WAS NOT RETURNED AND INVESTIGATION OF IT COULD NOT BE PERFORMED, IT WAS NOT POSSIBLE TO CLARIFY THE CAUSE OF OCCURRENCE. ASHITAKA FACTORY HAS BEEN MAKING EFFORTS IN MAINTAINING THE QUALITY OF THE PRODUCT BY PERFORMING FOLLOWING CONTROLS. IN THE PRODUCT ASSEMBLING PROCESS, 100% VISUAL INSPECTION IS PERFORMED TO CONFIRM THAT THERE IS NO DEFORMATION ON THE COIL. AFTER THE PRODUCT ASSEMBLING PROCESS, THE OUTER DIAMETER IS MEASURED ON 100% BASIS TO CONFIRM THAT THERE IS NO ANOMALY IN IT. IN THE SHIPPING INSPECTION, THE SLIDING RESISTANCE OF DISTAL END IS MEASURED FOR EACH LOT TO CONFIRM THAT THERE IS NO ANOMALY IN THE LUBRICITY. IN THE SHIPPING INSPECTION, PULLING STRENGTH IS MEASURED ON SAMPLING BASIS FOR EACH PRODUCT CODE/LOT TO CONFIRM THAT THERE IS NO ANOMALY IN IT. THE INSTRUCTIONS FOR USE (IFU) OF THIS PRODUCT INCLUDES THE FOLLOWING WARNING: "IF ANY RESISTANCE TO THE RUNTHROUGH NS OR THE DILATATION CATHETER IS FELT DURING MANIPULATION OR IF THE SHAPE, BEHAVIOUR OR POSITION OF THE GUIDE WIRE'S TIP SEEMS IMPROPER, E.G., IN A CASE WHERE THE TIP IS TRAPPED DUE TO VESSEL SPASM OR SOME OTHER CAUSE OR THE TIP IS FOLDED AS SHOWN IN FIG. 2, STOP MANIPULATING THE GUIDE WIRE (AND THE CATHETER) AND DETERMINE THE CAUSE CAREFULLY BY FLUOROSCOPY AND TAKE SUITABLE REMEDIAL ACTIONS. THEN REMOVE THE GUIDE WIRE SLOWLY, WITHOUT TURNING, TO EXCHANGE IT FOR A NEW ONE. CONTINUING GUIDE WIRE OR CATHETER MANIPULATION IN THE SAID SITUATIONS MAY RESULT IN DAMAGE TO THE VESSEL, DAMAGE TO OR SEPARATION OF THE GUIDE WIRE'S TIP, AND/OR DAMAGE TO THE DILATATION CATHETER."

    Description of Event or Problem · 0

    TERUMO MEDICAL RECEIVED A REPORT INVOLVING A WIRE MALFUNCTION DURING A PERCUTANEOUS CORONARY INTERVENTION (PCI) PROCEDURE. THE RTNS WIRE WAS POSITIONED IN A BRANCH VESSEL. UPON REMOVAL, THE WIRE BEGAN TO FRAY, AND A WIRE FRACTURE OCCURRED. THE WIRE WAS NOT TRAPPED BEHIND A STENT OR ANY OTHER OBSTRUCTION. MOST OF THE FRACTURED WIRE WAS SUCCESSFULLY SNARED AND REMOVED. THE EVENT OCCURRED INTRA-OPERATIVELY. THE PATIENT REMAINED STABLE AND RECOVERED FROM THE PROCEDURE. NO BLOOD LOSS WAS REPORTED. ADDITIONAL INFORMATION RECEIVED ON 21 AUG 2025: THE ISSUE BECAME APPARENT UNDER FLUOROSCOPY WHILE ATTEMPTING TO RETRACT THE WIRE. NO TESTING WAS PERFORMED. A PORTION OF THE WIRE REMAINS IN THE PATIENT'S LEFT ANTERIOR DESCENDING (LAD) ARTERY. NO FURTHER ATTEMPTS WILL BE MADE TO RETRIEVE THE REMAINING WIRE. THE SAMPLE IS CONTAMINATED WITH BLOOD AND BODY FLUID BUT IS NOT CONTAMINATED WITH INFECTIOUS AGENTS OR ANTI-CANCER AGENTS.

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    2599026 RUNTHROUGH WIRE, GUIDE, CATHETER DQX TERUMO CORPORATION, ASHITAKA 25-1011 250108 04987350744340

    Patients

    Seq Age Sex Outcome Treatment
    1 NA Unknown Required Intervention SNARE